President Trump recently announced his plan to lower prescription drug costs. It’s a solid plan that strikes the delicate balance between promoting innovation with the need to ensure that consumers have access to the medicines they need at a price they can afford.
Meanwhile, liberal politicians are continuing their calls for government price controls on prescription drugs, all while trumpeting the virtues of single-payer health care. Both policies would lead to lower quality care, more limited access to needed cures, and result in much higher government spending.
What our health care system needs is more competition to drive down prices. This plan helps.
The Trump Administration is right to focus on policies that speed access to the marketplace for generic drugs and new cures. Lower prices won’t happen overnight, but the policies the president has proposed will make a difference.